Kelsey A Holiday1,2,3, Eva Pirogovsky-Turk1,3, Vanessa L Malcarne2,4, J Vincent Filoteo1,3, Irene Litvan5, Stephanie L Lessig5,6, David Song7, Dawn M Schiehser1,3. 1. Research Service, VA San Diego Healthcare System, San Diego 92161 USA. 2. SDSU/UC San Diego Joint Doctoral Program in Clinical Psychology, San Diego 92120 USA. 3. Department of Psychiatry, University of California San Diego, 92093 USA. 4. UC San Diego Moores Cancer Center, San Diego, 92093 USA. 5. Department of Neurosciences, University of California San Diego, San Diego 92093 USA. 6. Neurology Service, VA San Diego Healthcare System, San Diego 92161 USA. 7. Department of Neuroscience, University of California, Riverside 92521 USA.
Abstract
BACKGROUND: Visual Hallucinations (VH) are a common symptom experienced by individuals with Parkinson's disease (PD); however, a validated measure of VH has yet to be established for this population. The North-East Visual Hallucinations Interview (NEVHI), a promising VH measure, has not been well validated in PD. The aim of this study was to evaluate the convergent and discriminant validity of the NEVHI as well as the proportional identification and characteristics of VH in PD. METHODS: One hundred seventeen individuals with PD completed the NEVHI as well as evaluations of psychological, cognitive, motor, and visual functioning as measures of convergent and divergent validity. The hallucination items from the Neuropsychiatric Inventory (NPI) and the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Scale (MDS-UPDRS) were used to assess convergent validity. RESULTS: The NEVHI identified 20.5% of PD patients with VH, which consisted of all individuals detected by the MDS-UPDRS and NPI and nine additional individuals not detected by the other measures. The NEVHI was strongly correlated with the MDS-UPDRS hallucinations item, and weakly correlated with the NPI VH item. Weak to non-significant correlations were found between the NEVHI and measures of psychological, cognitive, motor, visual, and demographic characteristics. DISCUSSION: The NEVHI identified a greater number of individuals with VH than either the MDS-UPDRS or NPI. Results demonstrated good convergent validity between the NEVHI and a clinician-administered-to-patient-report measure of VH and excellent divergent validity, supporting the NEVHI as a valid and preferable measure for assessing the presence of VH in PD.
BACKGROUND:Visual Hallucinations (VH) are a common symptom experienced by individuals with Parkinson's disease (PD); however, a validated measure of VH has yet to be established for this population. The North-East Visual Hallucinations Interview (NEVHI), a promising VH measure, has not been well validated in PD. The aim of this study was to evaluate the convergent and discriminant validity of the NEVHI as well as the proportional identification and characteristics of VH in PD. METHODS: One hundred seventeen individuals with PD completed the NEVHI as well as evaluations of psychological, cognitive, motor, and visual functioning as measures of convergent and divergent validity. The hallucination items from the Neuropsychiatric Inventory (NPI) and the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Scale (MDS-UPDRS) were used to assess convergent validity. RESULTS: The NEVHI identified 20.5% of PDpatients with VH, which consisted of all individuals detected by the MDS-UPDRS and NPI and nine additional individuals not detected by the other measures. The NEVHI was strongly correlated with the MDS-UPDRS hallucinations item, and weakly correlated with the NPI VH item. Weak to non-significant correlations were found between the NEVHI and measures of psychological, cognitive, motor, visual, and demographic characteristics. DISCUSSION: The NEVHI identified a greater number of individuals with VH than either the MDS-UPDRS or NPI. Results demonstrated good convergent validity between the NEVHI and a clinician-administered-to-patient-report measure of VH and excellent divergent validity, supporting the NEVHI as a valid and preferable measure for assessing the presence of VH in PD.
Entities:
Keywords:
Neuropsychiatric Inventory; North East Visual Hallucinations Interview; Parkinson’s Disease; Unified Parkinson’s Disease Rating Scale; Validity; Visual Hallucinations
Authors: Hee Kyung Park; Jae Seung Kim; Ki Chun Im; Mi Jung Kim; Jae-Hong Lee; Myoung C Lee; Juhan Kim; Sun Ju Chung Journal: Can J Neurol Sci Date: 2013-09 Impact factor: 2.104
Authors: Prabitha Urwyler; Tobias Nef; René Müri; Neil Archibald; Selina Margaret Makin; Daniel Collerton; John-Paul Taylor; David Burn; Ian McKeith; Urs Peter Mosimann Journal: Am J Geriatr Psychiatry Date: 2015-10-21 Impact factor: 4.105
Authors: Urs Peter Mosimann; Daniel Collerton; Robert Dudley; Thomas Daniel Meyer; Gemma Graham; Jennifer Louise Dean; Daniel Bearn; Alison Killen; Lucy Dickinson; Mike Patrick Clarke; Ian Grant McKeith Journal: Int J Geriatr Psychiatry Date: 2008-07 Impact factor: 3.485
Authors: Johanna C Badcock; Frank Larøi; Karina Kamp; India Kelsall-Foreman; Romola S Bucks; Michael Weinborn; Marieke Begemann; John-Paul Taylor; Daniel Collerton; John T O'Brien; Mohamad El Haj; Dominic Ffytche; Iris E Sommer Journal: Schizophr Bull Date: 2020-12-01 Impact factor: 9.306
Authors: Federico Rodriguez-Porcel; Kathryn A Wyman-Chick; Carla Abdelnour Ruiz; Jon B Toledo; Daniel Ferreira; Prabitha Urwyler; Rimona S Weil; Joseph Kane; Andrea Pilotto; Arvid Rongve; Bradley Boeve; John-Paul Taylor; Ian McKeith; Dag Aarsland; Simon J G Lewis Journal: Transl Neurodegener Date: 2022-05-02 Impact factor: 9.883